# The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis

> **NCT00405665** · PHASE2 · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 20 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** L-arginine
- **DRUG:** L-arginine

## Key facts

- **NCT ID:** NCT00405665
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00405665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00405665, "The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00405665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*